The Power of Community: Translating Innovations into Care in NHL and HL - a Med Table Talk™

This 4-part Med Table Talk™ series, The Power of the Community: Translating Innovations into Care in NHL and HL, offers healthcare professionals a comprehensive look at current challenges and solutions in treating non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL). Expert faculty will discuss unmet needs for NHL patients, focusing on disease-specific and patient-related characteristics that inform care strategies. The series covers evidence-based approaches for selecting CAR T-cell and bispecific antibody therapies in NHL, with an emphasis on safety and efficacy data. Additionally, it explores community-based treatment practices, the role of interdisciplinary teams in optimizing patient care coordination, and the benefits of immune checkpoint inhibitors for managing relapsed/refractory HL.